LONDON (AP) -- GlaxoSmithKline PLC says it has finalized a deal to sell its research operations in Italy to Aptuit Inc.
Glaxo hasn't revealed financial terms for the deal disclosed on Thursday. Some 500 staff at a facility in Verona will be transferred from Glaxo to Aptuit.
The London-based drug maker will also continue to receive research & development services from Aptuit.
Glaxo had announced in February that it planned to stop discovery research in select neurosciences areas such as pain and depression -- impacting on research at the Italian facility.